Commercial Strategy
Developing strategies and solutions for products across the lifecycle to optimize product profiles, drive early commercial success, and maximize product value
Sell-Side Partnering
Securing non-dilutive capital and pharma partners' resources for clients
Business Development
Build the value story, construct high-impact marketing materials, identify optimal strategic partners, conduct outreach to global industry network, and facilitate due diligence and deal closing
Transaction Advisory
Create deal tension through a structured process, conduct asset valuation and deal comparables analyses to optimize financial terms, and leverage substantial LifeSci transaction experience to support negotiations
Buy-Side Partnering
Securing assets or companies to bolster clients' product portfolios
Search & Evaluation
Utilize client parameters of interest to identify opportunities, prioritize/tier identified opportunities, and leverage BD expertise and network to vet availability / transactability
Commercial Due Diligence
Evaluate the scientific, regulatory, and commercial merits of potential opportunities – backed by primary research (e.g., physicians, payers, patients) – and leverage LifeSci platform to understand investor sentiment on opportunities
Proven Success
We leverage LifeSci’s global industry relationships and decades of transaction experience to drive our clients’ business development initiatives
Global industry network, including over 5,000 contacts
Experience across global markets (U.S., EU, Asia, LATAM, MENA)
Highlighted Deals
2022
![]()
![]()
Option to License
~$27M Equity Investment
2021
![]()
![]()
Exclusive License
$420M
2021
![]()
![]()
Exclusive China License
Undisclosed
2021
![]()
![]()
Exclusive License
Undisclosed
2019
![]()
![]()
Exclusive License
Undisclosed
2019
![]()
![]()
Exclusive License
$568M
2019
![]()
![]()
Option to License
$481M
2018
![]()
![]()
Acquisition
$420M
2018
![]()
![]()
Exclusive China License
$9.5M
2018
![]()
![]()
Product Acquisition
$30M
2016
![]()
![]()
Exclusive License
$469M
2016
![]()
![]()
Exclusive License
$230M
2016
![]()
![]()
Exclusive License
$100M
2015
![]()
![]()
Distribution Agreement
Undisclosed
2015
![]()
![]()
Product Acquisition
Undisclosed
2015
![]()
![]()
Exclusive License
$85M
2015
![]()
![]()
M&A
$30M
2014
![]()
![]()
Exclusive China License
$9M
2014
![]()
![]()
Exclusive License
Undisclosed
2013
![]()
![]()
Exclusive License
$121M
2012
![]()
![]()
Exclusive License
Undisclosed
2010
![]()
![]()
Exclusive License
$625M
2009
![]()
![]()
Exclusive License
$200M
2008
![]()
![]()
Exclusive License
$385M
Want to learn more?
We bring decades of experience to your challenges with a team that is uniquely designed to meet your needs